New advances in CMV and immunosenescence
- Sansoni, Paolo
- Vescovini, Rosanna
- Fagnoni, Francesco F.
- Akbar, Arne
- Arens, Ramon
- Chiu, Yen-Ling
- Čičin-Šain, Luka
- Dechanet-Merville, Julie
- Derhovanessian, Evelyna
- Ferrando-Martinez, Sara
- Franceschi, Claudio
- Frasca, Daniela
- Fulöp, Tamas
- Furman, David
- Gkrania-Klotsas, Effrossyni
- Goodrum, Felicia
- Grubeck-Loebenstein, Beatrix
- Hurme, Mikko
- Kern, Florian
- Lilleri, Daniele
- López-Botet, Miguel
- Maier, Andrea B.
- Marandu, Thomas
- Marchant, Arnaud
- Matheï, Catharina
- Moss, Paul
- Muntasell, Aura
- Remmerswaal, Ester B.M.
- Riddell, Natalie E.
- Rothe, Kathrin
- Sauce, Delphine
- Shin, Eui-Cheol
- Simanek, Amanda M.
- Smithey, Megan J.
- Söderberg-Nauclér, Cecilia
- Solana, Rafael
- Thomas, Paul G.
- van Lier, Rene
- Pawelec, Graham
- Nikolich-Zugich, Janko
DOIAbstract
AbstractImmunosenescence, defined as the age-associated dysregulation and dysfunction of the immune system, is characterized by impaired protective immunity and decreased efficacy of vaccines. An increasing number of immunological, clinical and epidemiological studies suggest that persistent Cytomegalovirus (CMV) infection is associated with accelerated aging of the immune system and with several age-related diseases. However, current evidence on whether and how human CMV (HCMV) infection is implicated in immunosenescence and in age-related diseases remains incomplete and many aspects of CMV involvement in immune aging remain controversial. The attendees of the 4th International Workshop on “CMV & Immunosenescence”, held in Parma, Italy, 25...
Add to ORKG